P-MEC South East Asia

New for 2013    P-MEC showcases innovative pharmaceutical machinery, laboratory equipment and analytical technology through face to face networking and education.Government funding of finished dosage and generics continue to drive rapid growth in the manufacture base throughout Southeast Asia, requiring infrastructure investment and machinery to meet the demand.P-MEC brings the well-known pharma machinery event from Europe, India and China to CPhI Southeast Asia to build the industry.

The Indonesian pharma market:

Indonesia alone represents the world’s fourth most populous country with 238 million people and a CAGR of 11% well above the world’s average. The Deputy Minister of Health spoke to the region’s huge growth potential at CPhI SEA in 2012: “Rapid population growth and the improving economy are factors that will increase drug consumption here.” Describing the government’s 2014 social insurance programme designed to provide free healthcare for 76.4 million people, he added“...if the poor people get sick, there’s no need for them to pay, as everything is already paid by the government. Under such a situation, we have many opportunities for investors and drug manufacturers to produce and to meet the need and demand for drugs to the community.”   

At the same time, ongoing harmonisation across the ASEAN (Association of South East Asian Nations) promises to make the entire region more competitive and powerful in the world market. Vietnam’s pharma industry is expected to have a CAGR of 24% with Malaysia, the Philippines, Thailand and Singapore also poised for growth.